Daiichi Sankyo U3-1402 breast cancer

Daiichi Sankyo reports positive results from Phase I/II U3-1402 trial

Daiichi Sankyo has reported new positive efficacy and safety results from its ongoing Phase I/II study of U3-1402 in heavily…